Clinigen Group plc (CLIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 18, 2015
Pages: 27
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C366FF9B48DEN
Leaflet:

Download PDF Leaflet

Clinigen Group plc (CLIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Clinigen Group plc (Clinigen Group) is a specialty pharmaceutical company. It carries out the licensing and revitalizing of niche, hospital only critical care medicines. The company also sources and supplies own and other pharmaceutical companies’ products to meet unmet medical needs or for use in clinical trials. The company operates through three divisions, such as Clinigen CTS, Clinigen GAP and Clinigen SP. Its Clinigen CTS division concentrates on global sourcing and supply of commercial medicines for clinical study use. Clinigen Group’s clinigen clinical trials supply division provides commercial medicines for use in clinical trials, globally and across various therapeutic areas. The company’s clinigen global access programs division specializes in the consultancy, management, development and implementation of access programs. It operates through its offices in Philadelphia, the US; and Tokyo, Japan. Clinigen Group is headquartered in Burton-on-Trent, Staffordshire, the UK.

Clinigen Group plc (CLIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Clinigen Group Acquires Ethyol from AstraZeneca
Clinigen Acquires Savene, Oncology Support Therapy, From SpePharm
Clinigen Acquires Cardioxane, Oncology Support Therapy, From Novartis For US$33 Million
Clinigen Group Acquires Foscavir From AstraZeneca For US$13 Million
Merger
Keats Healthcare and Clinigen Healthcare Merge with Clinigen
Licensing Agreements
Clinigen Extends Licensing Agreement with Hospira for Foscavir
Clinigen Enters Into Licensing Agreement With Theravance For Vibativ
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir
NobelPharma Enters Into Licensing Agreement With Clinigen For Foscavir
Clinigen Enters Into Licensing Agreement With Hospira For Foscavir
Equity Offering
Clinigen Completes IPO For US$16 Million
Acquisition
Clinigen Group Acquires Idis Group for USD338 Million
Clinigen Group plc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Clinigen Group plc, Pharmaceuticals & Healthcare, Key Facts, 2014
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Clinigen Group plc, Deals By Therapy Area, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Clinigen Group Acquires Ethyol from AstraZeneca
Clinigen Acquires Savene, Oncology Support Therapy, From SpePharm
Clinigen Acquires Cardioxane, Oncology Support Therapy, From Novartis For US$33 Million
Clinigen Group Acquires Foscavir From AstraZeneca For US$13 Million
Keats Healthcare and Clinigen Healthcare Merge with Clinigen
Clinigen Extends Licensing Agreement with Hospira for Foscavir
Clinigen Enters Into Licensing Agreement With Theravance For Vibativ
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir
NobelPharma Enters Into Licensing Agreement With Clinigen For Foscavir
Clinigen Enters Into Licensing Agreement With Hospira For Foscavir
Clinigen Completes IPO For US$16 Million
Clinigen Group Acquires Idis Group for USD338 Million
Clinigen Group plc, Key Competitors
Clinigen Group plc, Key Employees
Clinigen Group plc, Other Locations
Clinigen Group plc, Subsidiaries

LIST OF FIGURES
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Clinigen Group plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Clinigen Group plc (CLIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: